pharma · Age-related Macular Degeneration · Neovascular Age-related Macular Degeneration · OTLK
Outlook Therapeutics NL
Outlook Therapeutics NL B. V.
Outlook Therapeutics NL trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.
Cranbury, USA HQ
2011 Founded
59 Employees
Public company Type
OTLK · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cranbury, USA
- Founded
- 2011
- Employees
- 59
- Programs
- 2
- Drugs
- 3
- Patents
- 2
Outlook Therapeutics NL clinical trials
Registry index of 5 ClinicalTrials.gov studies linked to Outlook Therapeutics NL programs — each row shows trial ID, program name, phase, status, and indication.
Outlook Therapeutics NL trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Outlook Therapeutics NL.